Answer
No, an interaction study in patients with moderate-to-severe psoriasis found that 12 weeks of ixekizumab administration had no clinically significant effect on warfarin pharmacokinetics.
Sources for this answer
- Taltz 80 mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 18Document updated
Sources checked